Skip to main contentAI and Advanced
/
FORTIS · NSEBSE SENSEX77,537.72+0.82%BSE |
NIFTY 5024,231.85+0.64%NSE |
NIFTY BANK57,495.9+0.45%NSE |
NIFTY IT30,673.05+0.79%NSE |
NIFTY AUTO29,301.75+0.40%NSE |
NIFTY FMCG47,863.25+0.82%NSE |
NIFTY PHARMA26,416+0.39%NSE |
NIFTY 50023,512.95+0.54%NSE |
FO
NSE · Equity shares · Healthcare Facilities5.50 · 0.60%
Fortis Healthcare FORTIS
NSE:INR 916.8
BSE:INR 935
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for FORTIS
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 911.3
Day rangeINR 911.05 — INR 920.95
52-week rangeINR 766.8 — INR 1,104.3
Volume6.55 L
Market cap70,588.59
P/E57.61
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)9,127.84
Net Income (INR Cr)1,041.77
Rev Growth (5 Year %)17.76
P/E Ratio57.61
Book Value60.28
EPS14.01
Price/BV15.21Computed
Research path: Interpret Fortis Healthcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
FORTISFortis Healthcare1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 15,966.23 | 13,691.53 | 13,288.78 |
| Accumulated Depreciation Total | -2,233.6 | -1,911.06 | -1,536.34 |
| Cash Equivalents | 310.67 | 79.92 | 178.21 |
| Other Liabilities Total | 233.17 | 163.67 | 147.37 |
| Accrued Expenses | 37.8 | 38.64 | 2.69 |
| Long Term Debt | 2,394.39 | 2,078.72 | 733.76 |
| Common Stock Total | 754.96 | 754.96 | 754.96 |
| Other Equity Total | -137.14 | -150.48 | -152.93 |
| Other Current Assets Total | 18.4 | 9.47 | 9.66 |
| Prepaid Expenses | 32.57 | 33.92 | 28.16 |
| Total Assets | 15,966.23 | 13,691.53 | 13,288.78 |
| Current Portof LT Debt/Capital Leases | 453.63 | 120.5 | 100.52 |
| Additional Paid-In Capital | 7,215.19 | 7,215.19 | 7,215.19 |
| Cash | 96.3 | 59.8 | 57.06 |
| Total Equity | 9,895.55 | 8,916.52 | 7,662.9 |
| Long Term Investments | 228.66 | 172.22 | 232.57 |
| Retained Earnings(Accumulated Deficit) | 2,062.54 | 1,096.85 | -154.33 |
| Total Common Shares Outstanding | 75.5 | 75.5 | 75.5 |
| Property/Plant/Equipment Total-Gross | 9,553.49 | 8,163.13 | 7,344.35 |
| Tangible Book Valueper Share Common Eq | 60.28 | 57.46 | 40.47 |
| Goodwill Net | 4,721.26 | 4,194.16 | 4,194.16 |
| Total Liabilities | 6,070.68 | 4,775.01 | 5,625.88 |
| Total Debt | 3,472.58 | 2,475.11 | 1,155.02 |
| Short Term Investments | 151.7 | 365.98 | 365.03 |
| Cashand Short Term Investments | 558.67 | 505.71 | 600.3 |
| Total Receivables Net | 1,057.49 | 796.59 | 658.96 |
| Notes Payable/Short Term Debt | 81.46 | 43.29 | 68.68 |
| Deferred Income Tax | 512.07 | 439.83 | 429.28 |
| Accounts Receivable-Trade Net | 1,044.97 | 785.41 | 628.54 |
| Property/Plant/Equipment Total-Net | 7,319.89 | 6,252.07 | 5,808.01 |
| Minority Interest | 272.96 | 252.87 | 893.24 |
| Total Current Liabilities | 2,115 | 1,607.31 | 3,170.17 |
| Total Inventory | 152.28 | 125.68 | 123.52 |
| Accounts Payable | 943.11 | 807.62 | 727.79 |
| Other Currentliabilities Total | 598.99 | 597.28 | 2,270.49 |
| Total Long Term Debt | 2,937.49 | 2,311.32 | 985.82 |
| Intangibles Net | 623.1 | 384.09 | 413.45 |
| Other Long Term Assets Total | 215.01 | 368.31 | 370.67 |
| Note Receivable-Long Term | 1,038.89 | 849.32 | 849.33 |
| Total Current Assets | 1,819.42 | 1,471.36 | 1,420.59 |
| Capital Lease Obligations | 543.1 | 232.61 | 252.06 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio3.2
Price to Sale Ratio7.73
Growth
Debt 5Yr CAGR %17.8
Margins
Operating Margin 12m17.67
Operating Margin 5y Avg15.64
Net Profit Margin 12m11.66
Net Profit Margin 5y11
Yield
Dividend Yield %0.11
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk25.12
Analyst consensus
ConsensusBuy
Consensus score2.00
Analyst opinions17
Strong Sell count0
Sell count1
Hold count3
Buy count8
Strong Buy count5
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
| Global Health | INR 1,440.1 | 38,871.79 | 63.65 | — |
Shareholding
Ownership
- Promoter
- 31.17%
- FII
- 25.20%
- MF
- 25.81%
- Other
- 17.82%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Fortis Hospital Bannerghatta Road Performs World’s First Reported Combined Robotic Heart Bypass, Robotic Hernia And Circumcision Surgeries Performed Under Single Anesthesia On An 81-Year-Old Male Patient. - TRIPURA STAR NEWSMarket news · 21 Jul 2026, 3:52 pm
Fortis Hospital Bannerghatta Road Performs World’s First Reported Combined Robotic Heart Bypass, Robotic Hernia And Circumcision Surgeries Performed Under Single Anesthesia On An 81-Year-Old Male Patient. TRIPURA STAR NEWS
Fortis Hospital Noida performs world's first laparoscopic dual-lobe living donor liver transplant - Indian Pharma PostMarket news · 21 Jul 2026, 12:28 pm
Fortis Hospital Noida performs world's first laparoscopic dual-lobe living donor liver transplant Indian Pharma Post
Fortis Healthcare Appoints Vijender Singh as Agilus Diagnostics MD & CEO - HDFC SkyMarket news · 20 Jul 2026, 5:28 pm
Fortis Healthcare Appoints Vijender Singh as Agilus Diagnostics MD & CEO HDFC Sky
Delhi CM orders immediate inspection of Fortis Hospital in Shalimar Bagh - The News MillMarket news · 19 Jul 2026, 2:57 am
Delhi CM orders immediate inspection of Fortis Hospital in Shalimar Bagh The News Mill
IHH Healthcare to Advance Technology-based Healthcare Expansion in India Through Fortis - Digital Health NewsMarket news · 19 Jul 2026, 12:57 am
IHH Healthcare to Advance Technology-based Healthcare Expansion in India Through Fortis Digital Health News
Fortis Healthcare schedules 30th AGM on August 11, 2026 - scanx.tradeMarket news · 18 Jul 2026, 4:21 pm
Fortis Healthcare schedules 30th AGM on August 11, 2026 scanx.trade
Corporate actions
Events
- annual General MeetingAGM
- board MeetingsQuarterly Results
- dividendRs.1.0000 per share(10%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- annual General MeetingPOM
- annual General MeetingPOM
ShareKeyX Community
Discussion and sentiment for Fortis Healthcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Fortis Healthcare Limited is an India-based integrated healthcare service provider. The Company is primarily engaged in the business of healthcare services. Its segment includes the Healthcare business and the Diagnostics business. The healthcare business includes inpatient and outpatient services, sale of medical and nonmedical items and management fees from hospitals. The diagnostic business includes pathology and radiology services. Its specialties include Cardiac sciences, Oncology, Neurosciences, Gastroenterology, Orthopedics, and others. The healthcare verticals of the Company primarily consist of day care specialty, diagnostics and tertiary and quaternary care. The Company has approximately 27 healthcare facilities in India, 4750 operational beds. It operates in India, United Arab Emirates, Nepal, and Sri Lanka.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- FORTIS
- BSE Code
- 532843
Questions
Stock FAQ
What is the symbol and ISIN of Fortis Healthcare?
Fortis Healthcare has the symbol FORTIS and ISIN - INE061F01013.
What is the current price of Fortis Healthcare?
Fortis Healthcare is currently trading at INR 916.80.
What are the year high and year low of Fortis Healthcare?
Fortis Healthcare has a year high of INR 1,104.30 and a year low of INR 766.80.
What is the market capitalization of Fortis Healthcare?
Fortis Healthcare has a market capitalization of INR 70,588.59 crore.
What is the P/E ratio of Fortis Healthcare?
Fortis Healthcare has a P/E ratio of 57.61.
What is the dividend yield of Fortis Healthcare?
Fortis Healthcare has a dividend yield of 0.11%.
How is the financial performance of Fortis Healthcare based on revenue, net income, and EPS?
Fortis Healthcare has revenue of INR 9,127.84 crore, net income of INR 1,041.77 crore, and EPS of INR 14.02.
What is the book value of Fortis Healthcare?
Fortis Healthcare has a book value of INR 60.28.
What is the debt-to-equity ratio of Fortis Healthcare?
Fortis Healthcare has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Fortis Healthcare?
Fortis Healthcare has a price-to-book ratio of 15.21 and a price-to-sales ratio of 7.73.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.